[Adenylate cyclase complex, lipids and the regulation of the hormonal sensitivity of tumor tissue].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3023008)

Published in Eksp Onkol on January 01, 1986

Authors

L M Bershteĭn

Articles by these authors

(truncated to the top 100)

[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84

[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82

[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79

[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78

[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78

[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77

[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77

[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77

[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77

[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76

[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76

[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76

[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76

[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76

[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76

[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76

[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75

[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75

[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75

[Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation]. Vopr Med Khim (1979) 0.75

[Effect of phenformin on fetal mass in rats previously immunized with an extract of homologous thyroid gland]. Biull Eksp Biol Med (1981) 0.75

[Adipose and lean body mass in obese pre- and post-menopausal patients with breast cancer: the modifying role of smoking]. Vopr Onkol (1994) 0.75

[Cyclic nucleotides in clinical oncology]. Vopr Onkol (1982) 0.75

[Body weight, blood lipids, blood cortisol and prognosis of patients with cancer of the large intestine and breast]. Vopr Onkol (1989) 0.75

[Macrosomia and prognosis in cancer patients]. Vopr Onkol (1994) 0.75

[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75

[Fetal weight of rats preliminarily immunized with tissue extracts of heterologous and homologous thyroid gland]. Probl Endokrinol (Mosk) (1980) 0.75

[Lipoprotein lipase: properties, change in activity with age and in some noninfectious human diseases]. Vopr Med Khim (1997) 0.75

[Estrogen-dependent peroxidase and hormone-dependent carcinogenesis]. Vopr Onkol (1999) 0.75

[Correlation of hormone-metabolic status in breast cancer and effectiveness of adjuvant hormone therapy]. Vopr Onkol (2006) 0.75

[Effect of miskleron (clofibrate) on dimethylhydrazine induction of intestinal tumors in rats]. Biull Eksp Biol Med (1980) 0.75

[Effect of glucose on fetal weight and the transplacental blastomogenic effect of N-nitrosomethylurea in rats]. Eksp Onkol (1985) 0.75

[Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue]. Vopr Onkol (2001) 0.75

[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75

[Peroxidase activity in human uterine tissue: connection with clinico-morphological features of endometrial cancer]. Vopr Onkol (2001) 0.75

[Use of suppositories for rectal immunization]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75

[Morphometric and biochemical peculiarities of fatty tissue in patients with cancer of the breast and lung]. Vopr Onkol (1983) 0.75

[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75

[Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up]. Vopr Onkol (1987) 0.75

[Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients]. Vopr Onkol (1980) 0.75

[Carcinoembryonic antigen in the blood in the process of correcting carbohydrate metabolic disorders in patients with gastrointestinal cancer]. Med Radiol (Mosk) (1983) 0.75

[Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?]. Vopr Onkol (2005) 0.75

[Effect of systemic and central triiodothyronine administration on compensatory hypertrophy of the thyroid gland in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1980) 0.75

[Expression of proto-oncogenes myc and ras and hormonal regulation of adenylate cyclase in human colon tumor cells]. Dokl Akad Nauk SSSR (1989) 0.75

[Size and number of adipocytes in the perirenal fatty tissue in pregnancy and in the postpartum period in rats]. Biull Eksp Biol Med (1977) 0.75

[Current trends in the biological therapy of malignant tumors]. Vopr Onkol (1996) 0.75

[Comparative study of subcutaneous, rectal and peroral immunization with hormonal and nonhormonal proteins]. Patol Fiziol Eksp Ter (1978) 0.75

[Hormonal and progenotoxic properties of mammary fat in pre- and postmenopausal cancer patients]. Vopr Onkol (2006) 0.75

[Androstenedione conversion in human peripheral blood lymphocytes]. Biull Eksp Biol Med (1994) 0.75

[Properties of mammary fat in breast cancer patients: topographic, systemic and environmental factors]. Vopr Onkol (2007) 0.75

[75th anniversary of the publication of N. N. Petrov's manual "A General Theory of Tumors"]. Vopr Onkol (1985) 0.75

[Secretion of interleukin-1 beta and tumor necrosis factor by mononuclear cells in breast cancer patients: effect of body mass (composition), age and smoking]. Biull Eksp Biol Med (1996) 0.75

[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol (1996) 0.75

[Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking]. Vopr Onkol (2000) 0.75

[Specifics of reproductive disorders and hormonal sensitivity of tumors in patients with "hormone-related neoplastic syndrome"]. Vopr Onkol (1996) 0.75

[Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer]. Vopr Onkol (2007) 0.75

[Characteristics of the hormonal metabolic status of patients with colonic and rectal cancer]. Eksp Onkol (1988) 0.75

[Steroid-binding protein levels in breast cancer patients]. Vopr Onkol (2007) 0.75

[The adjuvant hormonal therapy of breast cancer]. Vopr Onkol (1995) 0.75

[Endocrine changes in cancer of the rectum and colon]. Vopr Onkol (1987) 0.75

[Cyclic adenosine monophosphate in the fatty tissue of breast and lung cancer patients]. Vopr Med Khim (1982) 0.75

[Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer]. Vopr Onkol (2007) 0.75

[Effect of human serum lipoproteins on various indices of thyroid function in rats]. Probl Endokrinol (Mosk) (1982) 0.75

[Cyclic adenosine monophosphate content in the lymphocytes of cancer patients]. Eksp Onkol (1985) 0.75

[Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma]. Vopr Onkol (2005) 0.75

[Aromatase activity in lymphocytes of cancer patients and healthy subjects]. Vopr Onkol (1990) 0.75

[Effect of thyroxine, insulin and cholesterol on the amount of cyclic adenosine monophosphate in normal and oncornavirus infected cells]. Tsitologiia (1977) 0.75

[Aromatase activity in breast cancer tissue: the role of a cellular substrate]. Biull Eksp Biol Med (1995) 0.75

[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue]. Biull Eksp Biol Med (1997) 0.75

[Penetration of 3H-cyclic adenosine-3',5'-monophosphate into different tissues of mice]. Biull Eksp Biol Med (1982) 0.75

[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75

[Features of blood gastrin in patients with colorectal cancer: possible prognostic significance]. Vopr Onkol (1994) 0.75

[Gail's coefficient in breast cancer patients with respect to menstrual status, body mass and estrogen receptor pattern of tumor]. Vopr Onkol (2004) 0.75

[Catecholestrogens: synthesis, properties and role in carcinogenesis]. Vopr Onkol (1997) 0.75

[The joker function of glucose in the development of main non-communicable human diseases]. Vestn Ross Akad Med Nauk (2005) 0.75

[Content of cyclic nucleotides, cholesterol and phospholipids in tumors of the large intestine]. Vopr Onkol (1985) 0.75

[Amplification of the heterologous response of adenylate cyclase in colonic tumors: relation to tissue lipid composition]. Vopr Med Khim (1988) 0.75

[Adrenal steroids in patients with breast cancer and in women with age-related impaired glucose tolerance]. Vopr Onkol (1996) 0.75

[Endocrine-genotoxic switchings as promoter of main noninfectious diseases]. Vestn Ross Akad Med Nauk (2008) 0.75

[Effect of phenformin on fat-carbohydrate metabolism in pregnant rats]. Biull Eksp Biol Med (1976) 0.75

[Adaptational and thyroid homeostasis and the state of fat and carbohydrate metabolism in lung cancer]. Vopr Onkol (1978) 0.75

[The assessment of the hormonal sensitivity of tumors of the large intestine in the adenylate cyclase test]. Vopr Onkol (1992) 0.75

[Antibodies to thyroglobulin in patients with cancer]. Vopr Onkol (1977) 0.75

[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. Vopr Onkol (1980) 0.75

[Molecular-genetic aspects of estrogen production. Aromatase gene]. Mol Biol (Mosk) (1998) 0.75

[Effect of preparations on the capacity of thyroxine to suppress compensatory thyroid hypertrophy in rats]. Farmakol Toksikol (1980) 0.75

[Evolutionary oncoendocrinology]. Zh Evol Biokhim Fiziol (2001) 0.75

[Dexamethasone and dibutyryl-cyclic AMP stimulates conversion of androstenedione in human blood lymphocytes]. Dokl Akad Nauk (1997) 0.75

[The effect of pharmacological preparations on the regulation of growth hormone secretion]. Probl Endokrinol (Mosk) (1994) 0.75

[Insulin-like growth factor-1, its binding protein (BP-3) and insulin in colorectal cancer]. Vopr Onkol (2001) 0.75

[Detection of antibodies to adipose tissue cell membranes in human blood]. Biull Eksp Biol Med (1991) 0.75

[The hormonal sensitivity of a transplantable adenocarcinoma of the large intestine]. Eksp Onkol (1990) 0.75

[Prognosis of breast cancer patients with large-fetus birth weights in their history]. Vopr Onkol (1981) 0.75

[Aromatase activity in human muscle tissue]. Vopr Med Khim (1997) 0.75

[Effect of phenformin (dibotin) on the state of fat-carbohydrate metabolism and fetal weight in pregnant rats previously given alloxan]. Patol Fiziol Eksp Ter (1977) 0.75

[Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis]. Vopr Onkol (2007) 0.75

[Cutaneous fat fold thickness, obesity characteristics and body surface in breast cancer and fibroadenomatosis]. Vopr Onkol (1979) 0.75

[Effect of hypolipidemic preparations on basal and stimulated adenylate cyclase activity in tumor cells]. Biull Eksp Biol Med (1985) 0.75

[Changes in skinfold thickness in the course of normal pregnancy and their relation to fetal weight]. Akush Ginekol (Mosk) (1980) 0.75

[Effect of thyroxine on radioactive iodine accumulation in the thyroid glands of hemithyroidectomized rats of different ages]. Biull Eksp Biol Med (1978) 0.75